SURUNKАLI YURАK YETISHMOVCHILI, EPIDEMIOLOGIYASI VА TАRQАLGАNLIGI
##article.subject##:
surunkali yurak etishmovchiligi, yurak-qon tomir kasalliklari, xavf omillari##article.abstract##
Surunkali yurak etishmovchiligi (SYuYe) bir qator irsiy, atrof-muhit va turmush tarzi omillari natijasida rivojlanadigan patologik holat bo'lib, hozirgi vaqtda yurak-qon tomir kasalliklarining asoratlari tufayli nogironlik, kasalxonaga yotqizish va o'limning asosiy sababi hisoblanadi. Ushbu maqolada SYuYe, epidemiologiya, tarqalish va xavf omillari haqida ma'lumot berilgan.
Библиографические ссылки
Braunwald E. The war against heart failure: the Lancet lecture // Lancet. -2015, № 385(9970) – P.812–24.
GBD 2017 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017 // Lancet.-2018, №392. – Р.1859-922.
Benjamin E.J., Muntner P., Alonso A., et al. Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association // Circulation.-2019, №139. – Р.e56-528.
Ionescu R.F., Cretoiu S.M. MicroRNAs as monitoring markers for right-sided heart failure and congestive hepatopathy // J Med Life. -2021, №14(2). – Р.142-147.
Ponikowski P., Voors A. A., Anker S. D. et al., “2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure // European Heart Journal. -2016, №37. – Р.2129–2200.
Mentz RJ, O'Connor CM. Pathophysiology and clinical evaluation of acute heart failure. Nat Rev Cardiol. (2016) 13:28–35. doi: 10.1038/nrcardio.2015.134
Savarese G., Lund L.H. Global Public Health Burden of Heart Failure // Cardiac Failure Review. -2017, №3. – Р.7-11.
Seferovic P.M., Ponikowski P., Anker S.D. et al. Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of The Heart Failure Association of the European Society of Cardiology // Eur J Heart Fail. -2019, №21. – Р.1169–1186.
Filippatos G., Farmakis D., Bistola V., Karavidas A., Mebazaa A., Maggioni A.P., Parissis J. Temporal trends in epidemiology, clinical presentation and management of acute heart failure: results from the Greek cohorts of the Acute Heart Failure Global Registry of Standard Treatment and the European Society of Cardiology Heart Failure pilot survey //Eur Heart J Acute Cardiovasc Care. -2014, №5. –Р.112-118.
Kurmani S., Squire I. Acute heart failure: definition, classification and epidemiology //Curr Heart Fail Rep. -2017, №14(5). – Р.385–92.
Andronic A.A., Mihaila S., Cinteza M. Heart Failure with mid-range ejection fraction – a new category of heart failure or still a gray zone //Maedica (Bucur).-2016, №11. – Р.320–324.
GBD 2016 Disease and Injury Incidence and Prevalence Collaborators, “Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 // Lancet.-2017, №390(10100). – Р.1211–1259.
GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013 // Lancet. -2015, №385. – Р.117–171.
Benjamin E.J., Blaha M.J., Chiuve S.E., et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics – 2017 update: a report from the American Heart Association // Circulation.-2017, №135. – Р.146–603.
Dokainish H., Teo K., Zhu J., et al. Global mortality variations in patients with heart failure: results from the International Congestive Heart Failure (INTER-CHF) prospective cohort study // Lancet Glob Health.-2017, №5. – Р.665-672.
MacDonald M.R., Tay W.T., Teng T.K., et al. Regional Variation of Mortality in Heart Failure With Reduced and Preserved Ejection Fraction Across Asia: Outcomes in the ASIAN-HF Registry // J Am Heart Assoc-2020, №9. – Р.012199.
Hao G., Wang X., Chen Z., Zhang L., Zhang Y., Wei B., et al. Prevalence of heart failure and left ventricular dysfunction in China: the China hypertension survey, 2012-2015 // Eur J Heart Failure. -2019,№21. – Р.1329–37.
Gedela M., Khan M., Jonsson O. Heart Failure // S D Med. -2015,№68(9). – Р.403-405.
Waikar S.S., Mount D.B., Curhan G.C. Mortality after hospitalization with mild, moderate, and severe hyponatremia // Am J Med. -2009, №122(9). – Р.857–865.
Фомин И. В. Агеев Ф.Т. и соавт. Эпидемиология хронической сердечной недостаточности в Российской Федерации // Хроническая сердечная недостаточность. М.:ГЭОТАР-Медиа, -2010, - С. 7-77.
Lawson C.A., Zaccardi F., Squire I., et al. 20-year Trends in Cause-Specific Heart Failure Outcomes by Sex, Socioeconomic Status, and Place of Diagnosis: A Population-Based Study // Lancet Public Health.-2019, №4. – Р.406-420.
